期刊论文详细信息
BMC Complementary and Alternative Medicine
Serum protein gamma-glutamyl hydrolase, Ig gamma-3 chain C region, and haptoglobin are associated with the syndromes of pulmonary tuberculosis in traditional Chinese medicine
Ji-Cheng Li1  Ze-Peng Ping1  Zhong-Liang Chen1  Dan-Dan Xu1  Li-Ying Shi2  Xiao-Mei Yu2  Li-Liang Wei3  Chong Wang1  Ting-Ting Jiang1 
[1] Institute of Cell Biology, Zhejiang University, Hangzhou, Zhejiang, China;Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, China;Department of Pneumology, The Sixth Hospital of Shaoxing, Shaoxing, Zhejiang, China
关键词: Tuberculosis;    Serum protein;    Erythrocyte sedimentation rate;    Pathology;    Traditional Chinese Medicine Syndrome;   
Others  :  1221185
DOI  :  10.1186/s12906-015-0686-4
 received in 2014-08-25, accepted in 2015-05-21,  发布年份 2015
PDF
【 摘 要 】

Background

Traditional Chinese Medicine (TCM) has been applied in treating tuberculosis (TB) based on the TCM syndromes with the effects of inhibiting Mycobacterium, strengthening the body immune system, and reducing the pulmonary toxicity. We used bioinformatic methods to study the clinical and pathological characteristics of pulmonary TB patients with TCM syndromes. Isobaric tags for relative and absolute quantification - coupled two dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) methods were applied to screen differentially expressed serum proteins.

Methods

Pulmonary TB cases were divided into four distinctive TCM syndromes: pulmonary Yin deficiency (PYD) syndrome, hyperactivity of fire due to Yin deficiency (HFYD) syndrome, deficiency of Qi and Yin (DQY) syndrome, and deficiency of Yin and Yang (DYY) syndrome. The serum samples from 214 pulmonary TB patients were collected, and the clinical and pathological data was analyzed by using iTRAQ-2DLC-MS/MS. Finally, the differentially expressed proteins were screened and tested by ELISA. Only 5 patients with DYY syndrome were recruited in 3 years, which were not enough for further research.

Results

The DQY cases had higher erythrocyte sedimentation rate (ESR) compared to the PYD and HFYD cases (P = 0.0178). 94.44 % (12 PYD, 18 HFYD, and 4 DQY before anti-TB treatment) of 36 treated TB cases were transformed to PYD accompanied with the reduction of ESR and absorption of pulmonary lesions. A total of 39 differentially expressed proteins (ratios of >1.3 or <0.75) were found among the three TCM syndromes. Proteomic studies revealed that gamma-glutamyl hydrolase (GGH), Ig gamma-3 chain C region (IGHG3), and haptoglobin (HPT) were specifically over-expressed in PYD (P < 0.01), HFYD (P < 0.001), and DQY cases (P < 0.01), respectively. Furthermore, GGH was significantly higher in PYD cases compared to the HFYD and DQY cases (P < 0.01, P < 0.001, respectively), whereas IGHG3 was significantly higher in HFYD cases than PYD and DQY cases (P < 0.001, P < 0.01, respectively).

Conclusions

The results suggest that TCM syndromes are significantly correlated with the pulmonary lesions and ESR. GGH was associated with folate metabolism in PYD cases, IGHG3 was linked to the control of Mycobacterium infection in HFYD patients, and HPT was involved in hypoxia in DQY patients. The present study provides new biological basis to understand the pathological changes and proteomic differences of TB syndromes.

【 授权许可】

   
2015 Jiang et al.

【 预 览 】
附件列表
Files Size Format View
20150728010703227.pdf 3435KB PDF download
Fig. 5. 39KB Image download
Fig. 4. 62KB Image download
Fig. 3. 32KB Image download
Fig. 2. 68KB Image download
Fig. 1. 85KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

【 参考文献 】
  • [1]Zumla A, George A, Sharma V, Herbert N. WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2013; 382:1765-1767.
  • [2]Tripathi RP, Bisht SS, Ajay A, Sharma A, Misra M, Gupt MP. Developments in chemical approaches to treat tuberculosis in the last decade. Curr Med Chem. 2012; 19:488-517.
  • [3]Burman WJ, Reves RR. Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers. Am J Respir Crit Care Med. 2001; 164:1112-1113.
  • [4]Tsuyuguchi K, Wada M. Management of adverse effects with antituberculosis chemotherapy [in Japanese]. Kekkaku. 2011; 86:87-99.
  • [5]Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM et al.. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl. 2010; 16:1136-1146.
  • [6]Wang M, Guan X, Chi Y, Robinson N, Liu JP. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): a systematic review of randomised clinical trials. Tuberculosis (Edinb). 2015.
  • [7]Xu M, Zhang M, Wang D, Yang CR, Zhang YJ. Phenolic compounds from the whole plants of Gentiana rhodantha (Gentianaceae). Chem Biodivers. 2011; 8:1891-1900.
  • [8]Xu HD, You CG, Zhang RL, Gao P, Wang ZR. Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages. J Int Med Res. 2007; 35:84-90.
  • [9]Wang L, Yang CL, Or TC, Chen G, Zhou J, Li JC et al.. Differential effects of Radix Paeoniae Rubra (Chishao) on cytokine and chemokine expression inducible by mycobacteria. Chin Med. 2011; 6:14. BioMed Central Full Text
  • [10]Lu J, Ye S, Qin R, Deng Y, Li CP. Effect of Chinese herbal medicine extracts on cell-mediated immunity in a rat model of tuberculosis induced by multiple drug-resistant bacilli. Mol Med Rep. 2013; 8:227-232.
  • [11]Pace E, Gjomarkaj M, Melis M, Profita M, Spatafora M, Vignola AM et al.. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit Care Med. 1999; 159:1592-1599.
  • [12]Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003; 284:L566-577.
  • [13]Godaly G, Young DB. Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation. Cell Microbiol. 2005; 7:591-601.
  • [14]Cheung BK, Lee DC, Li JC, Lau YL, Lau AS. A role for double-stranded RNA-activated protein kinase PKR in Mycobacterium-induced cytokine expression. J Immunol. 2005; 175:7218-7225.
  • [15]Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun. 1992; 182:1155-1159.
  • [16]Jacobs M, Brown N, Allie N, Gulert R, Ryffel B. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology. 2000; 100:494-501.
  • [17]Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol. 1998; 161:2636-2641.
  • [18]Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC et al.. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000; 105:1317-1325.
  • [19]Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM et al.. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol. 2002; 169:6343-6351.
  • [20]Cheung F. TCM: Made in China. Nature. 2011; 480:S82-3.
  • [21]Lin C, Zhu X, Deng K. Clinical researches on herbal Feifu – decoction therapy on drug-resistant Pulmonary Tuberculosis [in Chinese]. Chin Arch Tradit Chin Med. 2008; 26:2472-2473.
  • [22]Liu Y, He F. Chinese medicine in the treatment of tuberculosis of the status and prospect [in Chinese]. Guiding J Tradit Chin Med Pharmacy. 2010; 16:100-102.
  • [23]Kanawong R, Obafemi-Ajayi T, Ma T, Xu D, Li S, Duan Y. Automated tongue feature extraction for ZHENG classification in traditional Chinese medicine. Evid Based Complement Alternat Med. 2012; 2012:912852.
  • [24]Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet. 2008; 372:1938-1940.
  • [25]Wang SS, Zhou J, Zhang YF, Wang L, Feng X, Wang Y. Study on the Rule of TCM Syndromes in Pulmonary Tuberculosis [in Chinese]. World J Integ Tradit Western Med. 2014; 9:498-500.
  • [26]Wang SS, Zhou J, D F, Zhou JM. Research on TCM law of tuberculosis and related to objects indicators [in Chinese]. Clin J Chin Med. 2011; 3:13-14.
  • [27]Yang LS, Xu XE, Liu XP, Jin H, Chen ZQ, Liu XH et al.. iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p. J Proteomics. 2012; 77:480-491.
  • [28]Xu DD, Deng DF, Li X, Wei LL, Li YY, Yang XY et al.. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics. 2014; 14:322-331.
  • [29]Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu H et al.. iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J Proteome Res. 2011; 10:3418-3428.
  • [30]Liu J, Li Y, Wei L, Yang X, Xie Z, Jiang T et al.. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis. J Ethnopharmacol. 2014; 155:1322-31.
  • [31]Xu D, Li Y, Li X, Wei LL, Pan Z, Jiang TT et al.. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics. 2015; 15:58-67.
  • [32]Kobayashi K, Kaneda K, Kasama T. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech. 2001; 53:241-5.
  • [33]Turken O, Kunter E, Sezer M, Solmazgul E, Cerrahoglu K, Bozkanat E et al.. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2002; 6:927-932.
  • [34]Sahin F, Yazar E, Yildiz P. Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidiscip Respir Med. 2012; 7:38. BioMed Central Full Text
  • [35]Yao R, Schneider E, Ryan TJ, Galivan J. Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. Proc Natl Acad Sci U S A. 1996; 93:10134-10138.
  • [36]Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D. Glutamyl hydrolase pharmacological role and enzymatic characterization. Pharmacol Ther. 2000; 85:207-215.
  • [37]Kim SE, Cole PD, Cho RC, Ly A, Ishiguro L, Sohn KJ et al.. gamma-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate. Br J Cancer. 2013; 109:2175-2188.
  • [38]Kompis IM, Islam K, Then RL. DNA and RNA synthesis: antifolates. Chem Rev. 2005; 105:593-620.
  • [39]Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M et al.. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem. 2013; 288:23447-23456.
  • [40]Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, Hill PC et al.. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One. 2011; 6:e26938.
  • [41]Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008; 8:34-47.
  • [42]Bajtay Z, Csomor E, Sandor N, Erdei A. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett. 2006; 104:46-52.
  • [43]Maglione PJ, Xu J, Casadevall A, Chan J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J Immunol. 2008; 180:3329-3338.
  • [44]Jäger L, Franklin KA, Midgren B, Löfdahl K, Ström K. Increased survival with mechanical ventilation in posttuberculosis patients with the combination of respiratory failure and chest wall deformity. Chest. 2008; 133:156-60.
  • [45]Penner C, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med. 1995; 151:867-72.
  • [46]Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al.. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149:818-24.
  • [47]Nickel D, Busch M, Mayer D, Hagemann B, Knoll V, Stenger S. Hypoxia triggers the expression of human beta defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages. J Immunol. 2012; 188:4001-4007.
  • [48]Mairbaurl H, Weber RE. Oxygen transport by hemoglobin. Comprehensive Physiol. 2012; 2:1463-1489.
  • [49]Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011; 42:1781-1786.
  • [50]Babu R, Bagley JH, Di C, Friedman AH, Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage- induced secondary brain injury and as potential targets for intervention. Neurosurg Focus. 2012; 32:E8.
  • [51]Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014; 115:25-44.
  • [52]Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC et al.. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci. 2009; 29:15819-15827.
  文献评价指标  
  下载次数:13次 浏览次数:28次